The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.

The present invention is directed to novel retinoid-related orphan receptor gamma (ROR) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by ROR.

Provided herein according to some embodiments is a compound of Formula (I): [Formula], or a pharmaceutically acceptable salt or prodrug thereof. Compositions comprising the compound, and uses thereof for inhibiting the activity of quinone reductase-2, as well as in methods of treatment, are also provided. ##STR00001##

Provided herein according to some embodiments is a compound of Formula (I): [Formula], or a pharmaceutically acceptable salt or prodrug thereof. Compositions comprising the compound, and uses thereof for inhibiting the activity of quinone reductase-2, as well as in methods of treatment, are also provided. ##STR00001##

The disclosure provides a compound, an organic electroluminescent device, and a display apparatus, relating to the field of display technology. The structure of the compound is represented by Chemical Formula 1. When applied to organic electroluminescent devices, this compound can enhance device performance.

The disclosure provides a compound, an organic electroluminescent device, and a display apparatus, relating to the field of display technology. The structure of the compound is represented by Chemical Formula 1. When applied to organic electroluminescent devices, this compound can enhance device performance.